Competitive Positioning Strategies for South Korean Biotech Companies
Competitive Positioning Strategies for South Korean Biotech Companies
RELEASE DATE
06-Nov-2003
06-Nov-2003
REGION
Asia Pacific
Asia Pacific
Research Code: 4097-01-00-00-00
SKU: HC00082-AP-MR_02810
$1,500.00
In stock
SKU
HC00082-AP-MR_02810
Description
South Korean biotechnology industry is poised to become an important biotechnology hub in Asia Pacific region. Strong government support, well developed infrastructure, and increasing scientific pool have created a positive environment for growth of industry. The private sector too has realized the growing importance of participation. Many biotech startups, pharmaceutical companies and chaebols have invested in biotech research. The South Korean investment community still considers the biotech investments to be risky propositions and prefer short term capital returns. However, increasing aging population and demand for newer products have created new opportunities for biotech companies in South Korea.
Table of Contents
Introduction
- Introduction
Market Overview and Opportunity Analysis
- Market Overview
- Opportunity Analysis
Introduction
Market Drivers
- Introduction
- Key Biotech Markets
Biotech Market in Asia Pacific
- Market Drivers
- Protection of Intellectual Property Rights
- Low Cost R&D Base
- Availability of Public Domain Knowledge Base
Market Overview
Sectors of Activity
Key Success Factors
SWOT Analysis of South Korea as a Biotech Hub
Attractiveness of South Korea as a Biotech Destination for International Players
Current Competitive Position of South Korea
Strategies for Achieving Competitive Success
South Korea's Future Position as a Biotechnology Hub
Popular Topics
South Korean biotechnology industry is poised to become an important biotechnology hub in Asia Pacific region. Strong government support, well developed infrastructure, and increasing scientific pool have created a positive environment for growth of industry. The private sector too has realized the growing importance of participation. Many biotech startups, pharmaceutical companies and chaebols have invested in biotech research. The South Korean investment community still considers the biotech investments to be risky propositions and prefer short term capital returns. However, increasing aging population and demand for newer products have created new opportunities for biotech companies in South Korea.
No Index | Yes |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | 4097-01-00-00-00 |
Is Prebook | No |